Larimar Therapeutics
Price & Volume
Stats
See more52W Range | $1.73-$6.42 |
Market Cap | $528.7M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.28 |
News
See moreYahoo Finance • last month
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
Yahoo Finance • 5 months ago
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Yahoo Finance • 6 months ago
Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia
Yahoo Finance • 6 months ago
Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
About
CEO | Dr. Carole S. Ben-Maimon M.D. |
CFO | Mr. Michael Celano CPA |
Address | Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 71 |
